TA
Toluwalase Awoyemi
Cardiovascular Disease Fellow
First Year (AY 2025-2026) · Massachusetts General Hospital
ORCIDTraining
Cardiovascular Disease Fellowship at Massachusetts General Hospital.
Education includes University of Ibadan.
Explore education and trainingResearch
51 attributed works, including 20 as first author. Explore the publications and documented research affiliations.
Explore researchEducation and training
University of Ibadan
Residency · Northwestern
Research
Publications
51 attributed works · 20 first author. Counts reflect resolved authorship and may be incomplete.
- 2026Advancements and Applications of Focused Assessed Transthoracic Echocardiography: A Narrative ReviewHealth Science Reportssenior author0 citesPMID 42146720
- 2026Rapid-access arrhythmia care as an integrated model: A RE-AIM guided systematic reviewPublic Healthsenior author0 citesPMID 42218878
- 2026Winter warmth, lasting change through physician advocacyJournal of the National Medical Association0 citesPMID 41513497
- 2026The Influence of Personal and Family Support on Maternal Cardiovascular Health: Insights from a TriNetX Studysenior author0 citesPMID 41902617
- 2026In Vivo Emergence of Oxacillin Resistance in <scp>mecA</scp> ‐Negative <scp>MSSA</scp> Endocarditis With Metastatic InfectionClinical Case Reports0 citesPMID 41852517
- 2026Liver Cirrhosis and In‐Hospital Outcomes in Patients With Sickle Cell CriseseJHaemsenior author0 citesPMID 41788339
- 2025Advancements in Artificial Intelligence in Noninvasive Cardiac Imaging: A Comprehensive ReviewClinical Cardiologysenior authorRCR 9.4422 citesPMID 39871619
- 2025Melanin Nanoparticles as a Safe and Effective Iron Chelation Therapy: An ex vivo Assessment of Placental Transfer in Pregnant Beta-ThalassemiaInternational Journal of Nanomedicine1 citesPMID 40356859
- 2025Psychosocial Stressors and Maternal Cardiovascular and Multisystem Morbidity (Circulation abstract)
- 2025Advances in Non-statin Lipid Therapies: A Narrative Review of Evolving Strategies for Cardiovascular Risk ReductionAmerican Journal of Cardiovascular Drugs1 citesPMID 40884609
- 2025Hypertrophic cardiomyopathy in Nigeria: protocol for a systematic reviewBMC Cardiovascular Disorders0 citesPMID 41013227
- 2025Advancing Cardio-Obstetric Care Through Digital Health Technologies: A Narrative ReviewESC Heart Failurefirst author1 citesPMID 41178633
- 2025Radiotherapy in Nigeria: a silent emergency in cancer careAnnals of Medicine and Surgerysenior author1 citesPMID 41377403
- 2025When Is the Broken Heart Most Dangerous? Assessing Risk Factors to Predict Inpatient Death in Takotsubo Cardiomyopathy: Analysis of the National Inpatient Sample for 2021Journal of the American Heart Association3 citesPMID 40673530
- 2025Employment-Related Social Determinants of Health and Cardiovascular Risk (AHA Scientific Sessions abstract)
- 2025Echoes of Inequity: A Critical Examination of the Past, Present, and Future of Cardiac Health EquityCurrent Cardiology Reportsfirst author2 citesPMID 40970997
- 2025Cirrhosis Is an Independent Risk Factor for Mortality in Ischemic Stroke—A Nationwide AnalysisInternational Journal of Hepatologysenior author1 citesPMID 40144590
- 2025A Systematic Review of Case Reports of New-Onset Atrial Fibrillation in COVID-19 PatientsCureus1 citesPMID 40091918
- 2025Individualized Cardiovascular Therapeutics Using Artificial Intelligence–Powered Cardiovascular ImagingJournal of Cardiovascular Pharmacologysenior author2 citesPMID 41442627
- 2025The hidden link between HIV and cardiomyopathy: unraveling HIV's impact on the heartFrontiers in Cardiovascular Medicinefirst author0 citesPMID 41019440
Sources
Roster sources establish the listed training role. Additional education, career, and research sources are added as the profile is enriched.
Program context: Cardiovascular Disease Fellowship